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ABSTRACT
DNA double-strand breaks drive genomic instability.
However, it remains unknown how these processes
may affect the biomechanical properties of the nu-
cleus and what role nuclear mechanics play in DNA
damage and repair efficiency. Here, we have used
Atomic Force Microscopy to investigate nuclear me-
chanical changes, arising from externally induced
DNA damage. We found that nuclear stiffness is sig-
nificantly reduced after cisplatin treatment, as a con-
sequence of DNA damage signalling. This soften-
ing was linked to global chromatin decondensation,
which improves molecular diffusion within the or-
ganelle. We propose that this can increase recruit-
ment for repair factors. Interestingly, we also found
that reduction of nuclear tension, through cytoskele-
tal relaxation, has a protective role to the cell and re-
duces accumulation of DNA damage. Overall, these
changes protect against further genomic instability
and promote DNA repair. We propose that these pro-
cesses may underpin the development of drug resis-
tance.
INTRODUCTION
Cells are known to respond to external stimuli through
changes to their biomechanical properties, such as cellular
stiffness. Some studies have previously related chemother-
apy treatments to changes in the stiffness of cells and tissues
(1,2). Chemotherapy agents such as cisplatin induce DNA
damage, and therefore their main mechanism of action oc-
curs within a nuclear context. However, little is known
about the biomechanical changes that might occur in the
organelle following DNA damage.
Cisplatin, specifically, creates adducts within the double
helix, which then lead to double-strand breaks (DSBs) in
the DNA during replication, through replication-fork col-
lapse (3).
DSBs can result in large genomic aberrations and are,
therefore, the most deleterious to the cell. In the event of
a DNA break, the cell activates DNA damage response
(DDR) pathways that allow detection and repair of this le-
sion. Failure to repair damage leads to cell death through
apoptosis, or to the propagation of mutations that drive ge-
nomic instability and cancer development (4–6).
It is well known that the ataxia-telangiectasia-mutated
(ATM) kinase localizes to regions of damage, where it
phosphorylates histoneH2AX, producing H2AX. This, in
turn, promotes the recruitment of multiple repair factors to
foci of damage (7,8). However, it is not yet known if DNA
damage, or DDR itself, could lead to alterations in nuclear
mechanics.
It is established that chromatin and the lamina are major
determinants of nuclear mechanics (9), and we have previ-
ously shown that a thicker nuclear lamina correlate with
higher nuclear stiffness (10). It is also well reported that
cancer cells change their stiffness compared to normal cell
(11), where these parameters may be perturbed. In the con-
text of DDR, local changes to the condensation state of
the chromatin occur (12), which are associated to the effi-
ciency of DNA repair and chromatin remodelling factors
are known to be recruited to foci of damage (13,14). Inter-
estingly, chromatin stiffness can be modified by nucleosome
epigenetics (15) and protein complexes (16). Moreover, cy-
toskeletal proteins are also present within the nucleus and
contribute to repair (17). As with DNA damage, it is still
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unknown how these alterations impact the physical proper-
ties of the nucleus.
Here, we investigated the relationship between DNA
damage and nuclear mechanics. We used Atomic Force Mi-
croscopy (AFM) to probemechanics of the nucleus ofmam-
malian cells and monitor changes that occur after treat-
ment with cisplatin. We found that, following DNA dam-
age, large-scale mechanical alterations to the nucleus arise,
caused by global decondensation of chromatin. This is de-
pendent on DDR activation and increases molecular diffu-
sion in the nucleus, potentially resulting in higher accessibil-
ity for repair factors. Surprisingly, we also found that me-
chanical relaxation of the nucleus, independently of chro-
matin, protects against genomic instability. Collectively, our
data reveal how changes to chromatin architecture follow-
ing DNA damage both suppress further genomic instability
and provide an environment to promote repair. These find-
ings may be harnessed to promote therapeutic approaches
(e.g. resistance within a tumour environment).
MATERIALS AND METHODS
Drug treatments
Cisplatin [cis-diammineplatinum(II) dichloride] (Sigma)
was resuspended in a 0.9%NaCl solution to a concentration
of 3.3 mM, following manufacturer’s instructions and used
at a concentration of 25M. Trichostatin A (TSA) (Sigma)
was resuspended to 6.6. mM in DMSO and used at 400 nM
in culturing medium, for 24 h. ATM inhibitor, KU55933
(Sigma), was resuspended in DMSO to 12.6 mM and used
at a concentration of 20 M, 30 min prior treatment and
then for the whole duration of cisplatin treatment in cul-
turing medium. Blebbistatin (Sigma) was resuspended to 50
mM in DMSO and used at a concentration of 50 M for 1–
2 h before AFM measurements and for 30 min, prior treat-
ment and then the whole duration of cisplatin treatment for
imaging. Latrunculin B (Sigma) was resuspended inDMSO
to a concentration of 12.6 mM and used at 1 M for 1 h be-
fore AFM measurements.
Cell culture and transfection
HeLa cells (ECACC 93021013) were cultured at 37◦C and
5% CO2 in MEM Alpha medium with GlutaMAX, sup-
plemented with 10% fetal bovine serum (Gibco) and 1%
penicillin/streptomycin (Gibco). HeLa cells were trans-
fected with 0.5 g pSNAPf-C1 plasmid (Addgene 58186)
using Lipofectamine 2000 (Invitrogen) and following man-
ufacturer’s instructions.
Nuclear isolation
Nuclei were prepared based on protocols in (10,18) HeLa
cells and bone-marrow mesenchymal stem cells were
washed with cold phosphate buffered saline (PBS), then
washed in cold Hypotonic Buffer N––10 mM Hepes pH
7.5, 2 mM MgCl2, 25 mM KCl, 1 mM PMSF, 1 mM DTT
and Protease Inhibitor Cocktail (Thermo Fisher Scientific).
Cells were then re-suspended in cold hypotonic buffer N
and incubated for 1 h on ice. Cells were homogenized on
ice, using a glass Dounce homogenizer (Wheaton). Sucrose
was added to the cell lysate to a final concentration of 220
mM and mixed well by inversion before centrifugation. The
pellet, corresponding to isolated nuclei, was washed in cold
Buffer N––10 mM Hepes pH 7.5, 2 mM MgCl2, 25 mM
KCl, 250 mM sucrose, 1 mM PMSF, 1 mM DTT Protease
Inhibitor Cocktail. The nuclei pellet was re-suspended in
PBS and used immediately for AFM measurements.
Immunofluorescence
HeLa cells grown on glass coverslips were incubated for 10
min at 37◦C and 5% CO2 with 1g ml
−1 Hoechst 33342
in growth medium. Stained cells were fixed in 4% (m/V)
paraformaldehyde (PFA).Residual PFAwas quenchedwith
50 mM ammonium chloride for 15 min at room tempera-
ture. Cells were then permeabilized and blocked for 15 min
with 0.1% (V/V) Triton X-100 and 2% (m/V) bovine serum
albumin (BSA) in Tris-Buffered Saline (TBS). Antibodies
were used as follows: mouse-Phospho-H2AX (Merck 05–
636) at 1:500 dilution, rabbit-Lamin B1 (Abcam ab16048)
at a dilution of 1:200, donkey anti-mouse Alexa Fluor 488-
conjugated (Abcam Ab181289) at 1:500 and donkey anti-
rabbit Alexa Fluor-488-conjugated (Abcam, Ab181346) at
1:500 dilution. For actin staining, fixed and permeabilized
cells were stained prior to immunofluorescencewith 165 nM
Rhodamine-Phalloidin (ThermoFisher) for 20 min. Cover-
slips were mounted on microscope slides with 10% (m/V)
Mowiol, 25% (m/V) glycerol, 0.2 M Tris–HCl, pH 8.5, sup-
plemented with 2.5% (m/V) of DABCO (Sigma).
Fluorescence imaging
Cells were visualized usingWide-field microscope Olympus
IXT1, or Confocal microscope LSM 880. For confocal mi-
croscopy, a Plan-Apochromat 63 × 1.4 NA oil immersion
lens (Carl Zeiss, 420782–9900-000) was used. Three laser
lines: 405, 488 and 561 nm, were used to excite Hoechst,
Alexa 488 and Alexa 647 fluorophores, respectively. Built-
in dichroic mirrors (Carl Zeiss, MBS-405, MBS-488 and
MBS-561) were used to reflect the excitation laser beams
onto cell samples. For fluorescence collection, the used
emission spectral bands were: 410–524 nm (Hoechst), 493–
578 nm (Alexa 488) and 564–697 nm (Alexa 647). The green
channel (Alexa 488) was imaged using a 1 gallium arsenide
phosphide (GaAsP) detector, while the blue (Hoechst) and
red (Alexa 647) channels were imaged using two multi-
anode photomultiplier tubes (MA-PMTs). For imaging ac-
quisition and rendering, ZEN software was used. Confocal
Images were deconvolved using the Zeiss Zen2.3 Blue soft-
ware, using the regularized inverse filter method.
For Wide-field microscopy, a PlanApo 100xOTIRFM-
SP 1.49 NA lens mounted on a PIFOC z-axis focus drive
(Physik Instrumente, Karlsruhe, Germany) was used, with
an automated 300W Xenon light source (Sutter, Novato,
CA, USA) with appropriate filters (Chroma, Bellows Falls,
VT, USA). QuantEM (Photometrics) EMCCD camera,
controlled by theMetamorph software (MolecularDevices)
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STORM imaging
Cells were seeded on pre-cleaned No 1.5, 25-mm round
glass coverslips, placed in 6-well cell culture dishes. Glass
coverslips were cleaned by incubating them for 3 h, in etch
solution, made of 5:1:1 ratio of H2O: H2O2 (50 wt. % in
H2O, stabilized, Fisher Scientific): NH4OH (ACS reagent,
28–30% NH3 basis, Sigma), placed in a 70
◦C water bath.
Cleaned coverslips were repeatedly washed in filtered water
and then ethanol, dried and used for cell seeding. Trans-
fected or non-transfected cells were incubated with 1g
ml−1 Hoechst 33342 in growth medium for 15 min at 37◦C,
5%CO2. Following this, cells were washed with PBS and
fixed in pre-warmed 4% (w/v) PFA in PBS and residual
PFA was quenched for 15 min with 50 mM ammonium
chloride in PBS. Immunofluorescence (IF) was performed
in filtered sterilized PBS, unless when anti-phospho anti-
bodies were used. Then, IF was performed in filtered ster-
ilized TBS. Cells were permeabilized and simultaneously
blocked for 30 min with 3% (w/v) BSA in PBS or TBS,
supplemented with 0.1% (v/v) Triton X-100. Permeabilized
cells were incubated for 1 h with the primary antibody
and subsequently the appropriate fluorophore-conjugated
secondary antibody, at the desired dilution in 3% (w/v)
BSA, 0.1% (v/v) Triton X-100 in PBS or TBS. The anti-
body dilutions used were the same as for the normal IF
protocol (see above), except from the secondary antibod-
ies which were used at 1:250 dilution. Following incuba-
tion with both primary and secondary antibodies, cells were
washed three times, for 10 min per wash, with 0.2% (w/v)
BSA, 0.05% (v/v) Triton X-100 in PBS or TBS. Cells were
further washed in PBS and fixed for a second time with
pre-warmed 4% (w/v) PFA in PBS for 10 min. Cells were
washed in PBS and stored at 4◦C, in the dark, in 0.02%
NaN3 in PBS, before proceeding to STORM imaging.
Before imaging, coverslips were assembled into the
Attofluor® cell chambers (Invitrogen). Imaging was per-
formed in freshly made STORM buffer consisting of 10%
(w/v) glucose, 10 mM NaCl, 50 mM Tris–pH 8.0, supple-
mented with 0.1% (v/v) 2-mercaptoethanol and 0.1% (v/v)
pre-made GLOX solution which was stored at 4 ◦C for up
to a week (5.6% (w/v) glucose oxidase and 3.4 mg/ml cata-
lase in 50 mM NaCl, 10 mM Tris–pH 8.0). All chemicals
were purchased from Sigma.
Imaging was undertaken using the Zeiss Elyra PS.1 sys-
tem. Illumination was from a HR Diode 642 nm (150 mW)
and HR Diode 488 nm (100 mW) lasers where power den-
sity on the sample was 7–14 kW/cm2 and 7–12 kW/cm2,
respectively
Imaging was performed under highly inclined and lam-
inated optical (HILO) illumination to reduce the back-
ground fluorescence with a 100× NA 1.46 oil immersion
objective lens (Zeiss alpha Plan-Apochromat) with a BP
420–480/BP495–550/LP 650 filter. The final imagewas pro-
jected on an Andor iXon EMCCD camera with 25 msec ex-
posure for 20000 frames for H2AX and 60msec for 60 000
frames for Hoechst imaging.
Image processingwas performed using the Zeiss Zen soft-
ware. Where required, two channel images were aligned fol-
lowing a calibration using pre-mounted MultiSpec bead
sample (Carl Zeiss, 2076–515). The channel alignment was
then performed in the Zeiss Zen software using the Affine
method to account for lateral, tilting and stretching between
the channels. The calibration was performed during each
day of measurements.
The images were then processed through our STORM
analysis pipeline using the Zen software. Single molecule
detection and localization was performed using a 9-pixel
mask with a signal to noise ratio of 6 in the ‘Peak finder’ set-
tings while applying the ‘Account for overlap’ function. This
function allows multi-object fitting to localize molecules
within a dense environment. Molecules were then localized
by fitting to a 2D Gaussian.
The render was then subjected to model-based cross-
correlation drift correction. The final render was then gen-
erated at 10 nm/pixel and displayed in Gauss mode where
each localization is presented as a 2D gaussian with a stan-
dard deviation based on its precision.
High-content screening
HeLa cells were seeded in clear-bottom, black-walled 96-
well plates at 10 000 cells/well in culturing medium and in-
cubated overnight at 37◦C, 5% CO2. For Blebbistatin pre-
treated cells, 50 MBlebbistatin was added prior to 4-h in-
cubation with 50 MBlebbistatin and 25 Mcisplatin. For
cisplatin-treated cells, only cisplatin was added at 25 M
for 4 h. Cells were then incubated for 15 min with Hoechst
dye, at 37◦C, 5% CO2 and fixed using 4%(m/v) PFA.
Cells were stained with 165 nM Rhodamine-Phalloidin
(ThermoFisher) for 20 min and 1:500 dilution of mouse-
Phospho-H2AX (Merck 05–636) antibody for 1 h, follow-
ing the immunofluorescence protocol. High-content imag-
ing was undertaken using a Cell Discoverer 7 (Zeiss), using
a Plan-Apochromat 20 × 0.7 NA objective. Hoechst, Alexa
488 and Rhodamine fluorophores were excited using LED
light at wavelengths 385, 470 and 567 nm, respectively. ZEN
software was used for image acquisition and images were
analysed using Zeiss Zen2.3 Blue software.
Multi-focal imaging and particle tracking analysis
Cells were transfected for 24 h with 0.5 g of pSNAPf-C1
(Addgene 58186) construct with Lipofectamine 2000 (Invit-
rogen), according to manufacturer’s instructions. Following
this, cells were treated with 25 Mcisplatin or 400 nMTSA
in growth medium for 24 h.
Cells transiently expressing pSNAPf-C1 construct were
labelled for 15 min with 10 nM SNAP-tag-JF549 ligand, in
cell culture medium at 37◦C, 5%CO2. Cells were washed for
three times with warm cell culture medium and then incu-
bated for further 30 min at 37◦C, 5% CO2. Cells were then
washed three times in pre-warmed FluoroBrite Dulbecco’s-
modified Eagle’s medium (ThermoFisher Scientific), before
proceeding to imaging.
Single molecule imaging was performed using an
aberration-corrected multifocal microscope (acMFM), as
described by Abrahamsson et al. (19). Briefly, samples were
imaged using 561 nm laser excitation, with typical irradi-
ance of 4–6 kW/cm2 at the back aperture of a Nikon 100
× 1.4 NA objective. Images were relayed through a custom
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microscope with focus stabilization. The acMFM detection
path includes a diffractive multifocal grating in a conjugate
pupil plane, a chromatic correction grating to reverse the
effects of spectral dispersion, and a nine-faceted prism, fol-
lowed by a final imaging lens.
The acMFM produces nine simultaneous, separated im-
ages, each representing successive focal planes in the sam-
ple, with ca. 20 m field of view and nominal axial sepa-
ration of ca. 400 nm between them. The nine-image array
is digitized via an electron multiplying charge coupled de-
vice (EMCCD) camera (iXon Du897, Andor) at up to 32
ms temporal resolution, with typical durations of 30 s.
3D+t images of single molecules were reconstructed via
a calibration procedure, implemented in Matlab (Math-
Works), that calculates and accounts for (i) the inter-plane
spacing, (ii) affine transformation to correctly align each fo-
cal plane in the xy plane with respect to each other and (iii)
slight variations in detection efficiency in each plane, typi-
cally less than ±5–15% from the mean.
Reconstructed data were then subject to pre-processing,
including background subtraction, mild deconvolution (3–
5 Richardson-Lucy iterations) and/or Gaussian de-noising
prior to 3D particle tracking using the MOSAIC software
suite (20). Parameters were set wheremaximum particle dis-
placement was 400 nm and a minimum of 10 frames was re-
quired. Tracks were reconstructed, and diffusion constants
were extracted via MSD analysis (21) using customMatlab
software assuming an anomalous diffusion model.
Atomic force microscopy
AFM measurements were performed with an MFP 3D
BIO (Asylum Research, Oxford Instruments, Santa Bar-
bara, USA) on top of an inverted fluorescence microscope
(IX71, Nikon Instruments, Japan). The combined instru-
ment is mounted on a Halcyonics vibration isolation table
(Accurion GmbH, Göttingen, Germany) inside an acous-
tic enclosure (Asylum Research) to minimize noise. Force-
indentation curves were executed in contact mode using the
longer triangular cantilever of a TR 400 PB chip that has
a pyramidal tip with an opening angle of 35◦. The spring
constant was determined with the built-in macro based on
the thermal method and was in the range (28 -31 pN nm−1)
and therefore slightly stiffer than the nominal stiffness of
0.02 Nm−1. The nucleus was probed on several locations
using the ForceMap macro with a maximum indentation
force of 1.5 nN and the resulting force-indentation curves
were analysed using a modified Hertz model within a self-
written IGOR macro as described earlier (22,23).
Polyacrylamide gels
Elastic polyacrylamide (PA) gels were prepared as de-
scribed earlier (23,24). In brief, mixtures for the desired
elasticities were prepared using solutions of 40% acry-
lamide (#161–0140, Bio-Rad, Munich, Germany) and
2% bis-acrylamide (#161–0142, Bio-Rad, Munich, Ger-
many) in PBS that are stored at 4◦C for a maxi-
mum time of 2 months. These mixtures were polymer-
ized through addition of 1% (v/v) ammoniumpersulfate
and 0.1% (v/v) N,N,N,N-tetramethylethylenediamine onto
freshly plasma-cleaned cover slips that were treated with
3-aminopropyltriethoxysilane (Sigma, Munich, Germany,
A3648) and subsequently with a 0.05% glutaraldehyde so-
lution (Sigma, Munich, Germany, G7651) for firm attach-
ment of the gels. For 25 mm coverslips, 35 l of the PA gel
solution was dispensed and covered with a square super-
hydrophobic cover glass to equally distribute the solution.
Gels were polymerized for 60 min using a plastic box to
keep them in a saturated water atmosphere to avoid evap-
oration. For quality control the Young’s elastic modulus E
was regularly measured with a bulk rheometer (MCR-501,
Anton Paar, Austria) using a 2◦ cone and plate geometry.
To facilitate cell attachment, the gels were functionalized
with rat tail Collagen type I (0.2mg/mlCorning,NewYork,
NY, #354236) overnight at 4◦Cusing the heterobifunctional
crosslinker Sulfo-SANPAH (Thermo Scientific, Waltham,
MA, USA 22,589; 0.4 mM in 50 mM HEPES buffer at pH
8) active with UV light (λ = 365 nm) for 10 min.
Electron microscopy
Cells attached to Aclar membrane (Agar Scientific) were
fixed for 2 h in 2.5% glutaraldehyde (w/v) in 100 mM
sodium cacodylate (CAB) buffer pH 7.2. Samples were
washed twice for 10 min in 100 mM CAB and then post-
fixed in 1% osmium tetroxide (w/v) in 100 mM CAB for 1
h before being dehydrated using an ethanol series of 50%,
70%, 90% (v/v) and three times with 100% ethanol for 10
min per step. The samples were then placed into propylene
oxide, for (2×)10 min, and following this into a 1:1 mixture
of propylene oxide and Agar LV resin (Agar Scientific) for
30 min. Following this, samples were embedded in freshly
prepared Agar LV resin twice for 2 h before being placed in
shallow aluminiummoulds with the cells facing up andwere
polymerized at 60◦C for 24 h before being examined with a
dissecting microscope to identify areas confluent with cells.
These areas were cut out with a jig saw and attached to poly-
merized resin blocks with superglue, and once attached, the
Aclar membrane was peeled off, exposing a monolayer of
cells in the block face. Sections of 70 nm were cut on a Le-
ica EM UC7 ultramicrotome using a diamond knife (Di-
atome) and were collected on 400 mesh copper grids. Sec-
tions were counterstained in 4.5% uranyl acetate (w/v) in
1% acetic acid (v/v) for 45 min and in Reynolds’ lead citrate
for 7 min. Samples were viewed in a Jeol 1230 transmission
electronmicroscope and images were capturedwith aGatan
One View 16mp camera.
RESULTS
Whilst the biochemical responses to DNA damage are well
investigated (4,25,26), their effects on the biophysical prop-
erties of the nucleus are still poorly understood. To inves-
tigate this, we used cisplatin, a chemotherapy drug that
crosslinks DNA, thereby inducing DSBs within DNA and
AFM to measure mechanical changes in nucleus.
Cisplatin treatment reduces nuclear stiffness
Before AFM measurements, fully adhered cells on glass
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induced DNA damage, recorded as fluorescent foci of
H2AX (Figure 1A). AFMmeasurements were performed
at a central point above the nucleus of a selected cell, up
to a maximal force of 10 nN (Figure 1B and C). Force-
distance curves were then fitted using the Hertz model, to
determine the effective Young’s elastic moduli E. Figure 1D
shows representative experimental curves of deflection ver-
sus probe-sample separation and, in the insets, the fitted
curves.
We found that long treatment with cisplatin (24 h), but
not short treatment (4 h), significantly reduced cellular stiff-
ness (Figure 1E). Young’s modulus values changed from 4.4
± 0.6 kPa (mean ± SEM) in non-treated cells to 3.2 ± 0.4
kPa after cisplatin 4-h and 1.9 ± 0.2 kPa in cells, following
24-h cisplatin treatment. These results suggest that the ob-
served mechanical change is temporally separated from the
DNA damage itself. Therefore, breaks in DNA do not di-
rectly change the mechanical properties of the nucleus, but
rather trigger events that further downstream affect the nu-
clear stability.
Although these measurements were taken at a central
point above the nucleus, the complex actin cytoskeleton ex-
tends throughout the whole cell and exerts large amounts
of force on the nucleus through compression, thus altering
its physical properties and potentially masking mechanical
changes. As a result, it is difficult to understand what the in-
dividual contributions of the nucleus and the cytoskeleton
are to whole-cell mechanics.
To understand if the mechanical changes observed were
a result of alterations to the cytoskeleton, we labelled cells
with phalloidin after cisplatin treatment (Supplementary
Figure S1). Our data show that there is no actin cytoskele-
ton impairment, indicating that the observedmechanical ef-
fect is not a result of the dissociation of actin filaments in
the cell. We therefore postulated that the change in stiffness
could be the result of altered biophysical properties in the
nucleus.
To understand the individual contribution of the nucleus
to global mechanics, we decided to perform measurements
on cells at initial adhesion stages, isolated nuclei (Figure 2A
and Supplementary Figure S2) and cells treated with two
different cytoskeletal destabilizing drugs––Blebbistatin and
Latrunculin B (Supplementary Figure S1).
At initial adhesion stages, the nucleus is the largest con-
tributor to whole-cell mechanics. In this case, the cells are
given enough time to adhere to the surface (2–3 h for HeLa
cells) but the cytoskeleton and in particular stress fibres,
are not fully established (Supplementary Figure S1). As a
result, AFM measurements taken above the nucleus only
reflect the mechanical properties of the organelle. Alterna-
tively, Blebbistatin, a Myosin II inhibitor, and Latrunculin
B, an actin depolymerizing drug, relax the cytoskeleton (27–
29), and therefore measurements in these cells are mainly
directed at the nucleus, without a contribution from the cy-
toskeleton.
OurAFMdata show that, as expected, fully-adhered cells
(4.4 ± 0.7 kPa) are stiffer than Latrunculin B and Blebbis-
tatin treated cells (2.6 ± 1.2 kPa and 2.1 ± 0.8 kPa, respec-
tively), initially adhered cells (2.9 ± 0.3 kPa) and isolated
nuclei (2.6 ± 0.4 kPa), whilst there is no significant differ-
ence between these four latter conditions (Figure 2B).
From these data we confirmed that nuclear measure-
ments performed in initially-adhered cells are relatively free
of cytoskeletal contributions and that the nucleus remains
as the only large structural variable. Therefore, we decided
to use this approach to investigate changes to nuclear me-
chanics, as this allows for the physical properties of nucleus
to be probed whilst maintaining the organelle in its physio-
logical environment and without the use of drugs that may
have unknown effects in our study.
To investigate effects ofDNAdamage in nuclearmechan-
ics, we used 25 M cisplatin treatments for 4 and 24 h on
initially adhered HeLa cells, which were seeded on glass
slides 2 h before AFM measurements. This revealed that
theYoung’smoduli of nuclei were significantly reduced after
both 4 h (1. 6± 0.2 kPa, P< 0.001) and 24 h (1.2± 0.3 kPa,
P < 0.001) of cisplatin treatment (Figure 2C). Surprisingly,
we could observe mechanical changes after short cisplatin
treatment in initially adhered cells (Figure 2C), whilst this
was not possible in fully adhered (Figure 1C). This suggests
that cytoskeletal contributions, present in fully adhered cells
may be masking smaller nuclear mechanical changes occur-
ring in shorter treatments.
To confirm that the observed effect is intrinsic to the nu-
cleus, we also performed these measurements on isolated
nuclei (Figure 2A), following 4-h cisplatin treatment. Im-
munofluorescence images of isolated nuclei with membrane
dye DiD show that the nuclear membrane in isolated nuclei
is intact (Supplementary Figure S2). As expected, there is
a large decrease in Young’s moduli values from non-treated
nuclei (2. 6 ± 0.4 kPa) to cisplatin-treated (0.9 ± 0.2 kPa,
P< 0.0001), confirming these changes occur are intrinsic to
the nucleus (Figure 2D).
The mechanical response to DNA damage may be spe-
cific to the tumorigenic state of the cells because we did
not observe the DNA damage-induced decrease in stiffness
with bone-marrow mesenchymal stem cells, or isolated nu-
clei. (Supplementary Figure S3).
DNA damage signalling is required for mechanical changes
to the nucleus
As cisplatin treatment causes severe DNA damage, we won-
dered if these mechanical changes were dependent on DDR
signalling. FollowingDSBs,ATMkinase is recruited to sites
of damage, where it phosphorylates histone H2AX (30).
This results in the recruitment of repair factors toDSBs and
biochemical changes that determine the cell’s fate (7,31–33).
To investigate this, we inhibited theATMkinase, using in-
hibitor KU55933 (iATM) by pre-treating cells with iATM
for 30 min before 4-h treatment with 25 M cisplatin (also
in the presence of iATM). Immunofluorescence shows that
treatment with iATM impairs the formation of H2AX
foci (Figure 3A). AFM measurements on initially adhered
cells (Figure 3B) show no difference between nuclei of non-
treated cells (2.9 ± 0.3 kPa) and nuclei of cells treated with
cisplatin after pre-incubation with iATM (2.7 ± 0.3 kPa).
Surprisingly, these data suggest that mechanical changes to
the nucleus occur after DDR signalling is activated and ap-
pears to be dependent on ATM kinase. This confirms that
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Figure 1. AFMmeasurement of cisplatin treated cells. (A) Wide-Field immunofluorescence imaging of H2AX (green) in HeLa cells (scale bar = 10 m).
(B) Cartoon depicting AFMmeasurement. Cells are attached on glass, and a cantilever with a pyramidal tip is used to probe cellular mechanics at a central
point above the nucleus. (C) Transmitted light sample images from wide-field microscope coupled to AFM, showing non-treated cells and cells after long
cisplatin treatment (24 h). Scale bar 20 m. (D) Representative distance (Zsnsr) versus deflection AFM curves for all three conditions tested are shown,
with approach and retraction curves in red and blue, respectively. Curve fitting, shown above curves, was performed using the Hertz model, as described
in methods (E) Young’s moduli values for non-treated (n= 29), cisplatin 4 h (n= 29) and cisplatin 24 h (n= 34) treatments. Each point corresponds to the
average value for a cell, calculated from 10 measurements. Mean ± SE are represented in the plot and values are shown below each condition. P-values
were calculated by a two-tailed t-test, assuming equal variance; ***P < 0.001.
Mechanical changes of the nucleus after DNA damage are
caused by chromatin decondensation
The nuclear lamina is a major structural component of the
nucleus. We therefore tested if cisplatin treatment changed
lamina integrity, thus changing nuclear mechanics. Our re-
sults show that for non-treated and cisplatin-treated cells
there are no changes in thickness of the nuclear lamina
(Supplementary Figure S4A and B). Negative-stain elec-
tron microscopy (EM) data support this observation and
show that nuclear membrane integrity is not compromised
following cisplatin treatments (Supplementary Figure S4C).
This suggests that the reduction of the Young’s modulus of
the nucleus is not a result of a structural compromise to the
nuclear lamina.
Together with the lamina, chromatin compaction is one
of the other major contributors for nuclear mechanics, and
previous studies have suggested that the state of chromatin
condensation can change followingDSBs (14,34–36). If this
is the case, global changes to chromatin compaction could
result in significant alterations to nuclear mechanics.
To investigate this hypothesis, we used EM to image both
non-treated and cisplatin-treated cells and compared it to
TSA, a deacetylase inhibitor that leads to decondensation
of chromatin. Dense regions of staining corresponding to
condensed chromatin are clearly visible in the non-treated
cells. This contrasts with both cisplatin and TSA-treated
cells (Figure 4A). Quantification of chromatin compaction
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Figure 2. Initially adhered and isolated nuclei measurements in HeLa cells after DNA damage. (A) Representative transmitted light images fromwide-field
microscope coupled to AFM, showing initially adhered cells and isolated nuclei. (Scale bar 20 m) (B) Young’s moduli values for comparison between fully
adhered cells (n = 29), initially-adhered cells (n = 26), isolated nuclei (n= 32) and after cytoskeleton disruption with drugs LatB (n= 28) and Blebbistatin
(n = 13). (C) Young’s moduli of initially adhered cells after 4 (n = 17) and 24-h (n = 13) cisplatin treatments. (D) Values for AFM measurements of non-
treated isolated nuclei and nuclei isolated after 4-h cisplatin treatment (n = 40). Mean values ± SE are represented in the plot. P-values were calculated by
two-tailed t-test, assuming equal variance; ns > 0.05 *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
that cells treated with cisplatin have higher levels of de-
condensed chromatin, similarly to TSA-treated cells, whilst
non-treated cells have higher amounts of condensed chro-
matin (Figure 4B).
To test if chromatin decondensation, following TSA
treatment, had a similar effect to cisplatin on nuclear stiff-
ness, we measured the Young’s modulus in nuclei of initially
adhered cells. Our AFM data show (Figure 4C) that nuclei
in TSA-treated cells (1.0 ± 0.1 kPa) are significantly softer
than in non-treated cells (2.9 ± 0.3) and display similar me-
chanics to long-term cisplatin-treated cells (1.2 ± 0.3).
To complement EM data and confirm the observed ef-
fects of cisplatin on chromatin, we used super-resolution
STORM imaging. Standard antibody staining was used to
image H2AX, whilst we took advantage of the photophys-
ical properties of the Hoechst DNA dye to visualize chro-
matin (Figure 5A and B). Qualitatively, our results con-
firm that chromatin decondensation occurs after cisplatin
treatment (Figure 5A) compared to the non-treated sam-
ple, and similarly to TSA-treated cells (Figure 5B). In the
non-treated sample, clearly defined chromatin bundles are
present within the nuclear periphery and interior. However,
upon cisplatin treatment there are a few islands of con-
densed DNA but there is loss of the extensive network. The
extent of chromatin relaxation in this case is comparative to
TSA treatment. Taken together, these results strongly sug-
gest that chromatin decondensation is a determining factor
for changes in nuclear mechanics after DNA damage.
A possible benefit that arises from chromatin deconden-
sation is that it may allow for higher protein diffusion in the
nucleus, thus enabling repair factors to reach areas of dam-
age more easily. To test this, we usedMultifocalMicroscopy
(MFM) (19) and 3D single-particle tracking to measure the
diffusion constants of a fluorescently labelled SNAP tag
(37,38), expressed in HeLa cells, in treated and non-treated
conditions. MFM allows us to do live-cell, single-molecule
imaging across nine simultaneous z planes (Figure 5C) (19),
hence creating a comprehensive 3Dmodel of molecular dif-
fusion in nucleus. The SNAP tag was used as a reporter
of free diffusion within the nucleus. Figure 5D shows a
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Figure 3. ATM inhibition impairs nuclear mechanical response to DNA damage. (A) Confocal immunofluorescence imaging of H2AX (green), with
nuclear stain Hoechst, after cisplatin treatment in the presence or absence of ATM inhibitor (Scale bar = 10 m). (B) Young’s moduli values after short
and long cisplatin treatments, and in cells treated with both ATM inhibitor and cisplatin (n = 24). Cells treated with only iATM are also shown (n =
31). Plot shows mean values ± SE. P-values from two-tailed t-test, assuming equal variance between conditions are also shown (ns > 0.05; *P < 0.05;
**P < 0.01).
Our data show that the diffusion constant of the SNAP-
tag in the nucleus of cells treated with cisplatin (1.2 ±
0.04 m2/s) is significantly higher than in non-treated cells
(0.8 ± 0.03 m2/s), but similar to TSA-treated (1.3 ± 0.04
m2/s) (Figure 5E). This supports the idea that chromatin
decondensation following damage allows proteins to diffuse
more rapidly within the nucleus.
Mechanical relaxation of the nucleus protects cells from dam-
age
Recently, studies have linked the occurrence of DNA dam-
age to external forces exerted on the nucleus (39,40). Sim-
ilarly, there is some evidence that increased forces on the
nucleus exacerbate the extent of DNA damage (41,42). It
is possible that, after DNA damage, a softer nucleus, also
leads to a loss of tension on the nucleus which prevents fur-
ther genomic instability.
To investigate how forces exerted on the nucleus influence
DNA damage, we decided to pre-treat cells with Blebbis-
tatin for 30 min before 4-h treatment with cisplatin (also in
the presence of Blebbistatin). This allowed us to minimize
cytoskeletal forces on the nucleus prior to the occurrence of
damage. We used H2AX as a marker for damage. High-
content screening revealed a large decrease in the percent-
age of damaged cells when they pre-incubated with Bleb-
bistatin. In non-treated cells, only 5.1 ± 0.2% of the popu-
lation showed H2AX signalling, as expected. 37.4 ± 0.9%
of cisplatin-treated cells (short treatment) displayed signs of
damage, whilst this value dropped to 21.2 ± 0.6% for cells
that were pre-incubated with Blebbistatin (Figure 6A and
B). This suggests that a decrease in forces acting on the nu-
cleus has a protective effect towards DNA damage.
Matrix stiffness is tightly related to cell spread, adhesion
formation and cytoskeletal force (24,43,44). As a result, a
stiffer surface will create higher forces in the cytoskeleton,
which would then translate into higher mechanical con-
straints to the nucleus (45–47). To further explore this rela-
tionship between stiffness and the extent of DNA damage,
we used polyacrylamide gels of different stiffness (2, 11 and
30 kPa) as surfaces for cells (Figure 7A). The ability of the
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Figure 4. Electron Microscopy for quantification of chromatin condensation levels. (A) Electron microscopy of HeLa cells after long cisplatin treatment
and treatment with deacetylase inhibitor TSA. White squares on left panel represent area selected for detail on middle panel. Threshold images are shown
on the right panel (Scale bars = 2 m). (B) Quantification of dark and light pixels from electron microscopy images inside the nucleus, representing
condensed and decondensed chromatin. Values for non-treated cells are in black (n = 21), long cisplatin treatment in red (n = 26) and TSA (n = 26). (C)
Young’s moduli values of initially adhered cells, comparing non-treated and 24-h cisplatin treatment with TSA (n = 28). For all experiments, the mean
values ± SE are plotted. Statistical differences were calculated using two-tailed t-test, assuming equal variance between conditions and P-values are shown
(ns > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001).
measure the cross-sectional area of the nucleus. Here, the
greater tension exerted by the stiffer gel matrix leads to an
increase in nuclear area from 291.0 ± 8.5 m2 to 456.0 ±
10.8 m2 (Figure 7B), in line with earlier findings (48).
If we expect lower force to have a protective effect, lower
surface stiffness should decrease the amount of damage
in cells, in a similar way to Blebbistatin treatment. As ex-
pected, our data reveal that cells treated in stiffer gels, 30
kPa, have 65% higher levels of H2AX levels compared to
2 kPa gels and 30% higher than 11 kPa gels (Figure 7C).
Overall, less tension across the nucleus leads to less dam-
age.
DISCUSSION
Our work reveals a direct link between DNA damage, chro-
matin condensation and nuclear mechanics. It has been
shown that treatment with cisplatin and other chemother-
apy drugs changes whole-cell mechanics (49,50). However,
since most studies focus on cytoskeletal contributions, until
now it remained unclear how these DNA damage-causing
drugs alter the biomechanical properties of the nucleus.
Here, by performing AFM measurements in initially ad-
hered cells, we were able to probe the mechanical proper-
ties of the nucleus within its cellular environment. Our work
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Figure 5. Impact of DNA damage on chromatin organization and molecular diffusion in the nucleus. (A) Representative STORM images of chromatin
labelled with Hoechst of HeLa cells after cisplatin treatment, with immunolabelling of H2AX (red). Scale bar = 2 m. (B) STORM images of chromatin
in non-treated and TSA treated HeLa cells. (C) Cartoon depicting simultaneous acquisition of nine focal planes using multifocal microscopy for 3D single-
molecule tracking of a reporter SNAP-tag. (D) Example of 3D molecule trajectories under normal conditions. (E) Diffusion Coefficients calculated from
3D single-molecule tracking after fitting trajectories assuming an anomalous diffusion model. Plot shows mean values ± SE. P-values were calculated with
a two-tailed t-test, assuming equal variance (ns > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001).
to the state of chromatin condensation, which in turn results
in a reduction of nuclear stiffness. This response may be
specific to the tumorigenic background. However, a wider
study of more cell lines is required to specifically address
this point.
Mechanical changes to the nucleus do not arise sponta-
neously from breaks in the chromatin fibre, but are a result
of downstream large-scale chromatin decondensation. The
ATM kinase is activated by DNA damage, and its absence
or inactivity can lead to a proportion of unrepaired DSBs
in the cell (51,52). Interestingly, the mechanical softening of
the nucleus also appears to be coupled to the activity of the
ATMkinase, suggesting that chromatin decondensation oc-
curs as a result of the DDR. Several studies have reported
localized chromatin decondensation around areas of dam-
age and this is thought to lead to higher repair efficiency
(34,35,53). Our data largely agree with this observation, but
we cannot exclude that there are patches of condensedDNA
around the damage sites.Moreover, we show that chromatin
decondensation, following DNA damage, increases molec-
ular diffusion within the nucleus. By creating greater expo-
sure to DNA binding sites and enabling repair factors to
readily reach sites of damage, chromatin decondensation
could act as a major determinant for the outcome of repair
events.
Interestingly, we found that alterations to biomechanics
also appear to protect the cell from genomic instability. In
addition to the intrinsic mechanical properties of the nu-
cleus, the cytoskeleton also has a large impact on overall
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Figure 6. Impact of Blebbistatin on H2AX signalling in HeLa cells. (A) Representative images from high-content screening of HeLa cells treated with
cisplatin in the presence or absence of Blebbistatin. Nuclear staining with Hoechst and Actin labelling with Rhodamine phalloidin are shown in addition
to immunofluorescent labelling of H2AX. Scale bar = 100 m. (B) Levels of damage in HeLa cells from high-content screening, calculated as percentage
of nuclei displaying H2AX signalling. P-values are shown between non-treated cells (n = 58, representing 51 233 cells), 4-h cisplatin treatment (n = 70,
representing 63 422 cells) and combined Blebbistatin and cisplatin treatment (n = 68, representing 57 274 cells). For all conditions, mean values ± SE are
plotted. Two-tailed t-test, assuming equal variance, was used for P-value calculation (ns > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001).
reduced nuclear tension and, here, we show that this has a
protective effect in DNA damage. It has been shown that
reduction in matrix stiffness, a major determining factor
for cytoskeletal organization, correlates with inhibition of
replication (54–56). Cisplatin-induced DSBs require active
DNA replication. It is, therefore, possible that the lower lev-
els of DSBs detected in nuclei under lower mechanical ten-
sion are a result of altered DNA replication levels. We sug-
gest that a decrease in nuclear stiffness would also desta-
bilize cytoskeleton-nuclear linkage which could result in a
change in nuclear tension. Our findings agree with the re-
cent findings of Nava et al., which showed that nuclear soft-
ening protects against mechanically induced DNA damage
(41). Moreover, our observations build upon findings from
Kumar et al. (57), which revealed how theATRkinasemod-
ulates the nuclear membrane and chromatin in response to
mechanical stress. Overall, it appears that the nucleus has
an innate ability to protect against different agents.
Deformations to the nuclear envelope, as well as me-
chanical forces acting on the organelle are important for
the regulation of cell-cycle progression (58) and transcrip-
tion activity (59). Interestingly, DNA damage leads to
cell cycle arrest and transcriptional repression to promote
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Figure 7. Impact of nuclear relaxation on H2AX signalling in HeLa cells. (A) Representative Wide-field images of HeLa cells growing on gels of different
stiffness––2 and 30 kPa––after cisplatin treatment. Immunofluorescent labelling of H2AX is shown in red, with nuclear stain Hoechst in blue. (Scale bar
= 20 m). (B) Nuclear area of cells on different surfaces––2 kPa (n = 111), 11 kPa (n = 121) and 30 kPa (n = 139). P-values are shown. (C) Fluorescence
intensity of red channel (H2AX) within the nucleus of cells grown on surfaces of different stiffness––2 kPa (n = 90), 11 kPa (n = 79) and 30 kPa (n =
61). In all cases, mean values ± SE are shown. Two-tailed t-test, assuming equal variance, was used for statistical calculations and P-values are shown (ns
> 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001).
mechanosensing properties of the nucleus could contribute
to the regulation of these processes. In terms of cell cancer,
during migration and invasion, altered nuclear mechanics
may be an important factor. For example, whilst travelling
through confined spaces, cells with softer nuclei could mi-
grate more easily and with less DNA damage, induced by
rupture events resulting from nuclear compression. In this
case, a softer nucleus would, once again, protect from fur-
ther damage.
There is growing evidence that tumorigenesis and resis-
tance to chemotherapy agents correlate with changes in cel-
lular and nuclear mechanics (60). Depending on the cell
types and type of treatment, drug resistance has been asso-
ciated with an increase or decrease in cell stiffness (60,61).
Interestingly, there are also possible differences between in
vitro cell lines and patient-derived primary samples, where
the latter are more deformable. Our data fit with these sce-
narios, whereby decreased nuclear stiffness promotes repair
and prevents further damage, which could subsequently
drive drug resistance.
In summary, here, we describe how nuclear mechanics
change due to inducedDNAdamage through chromatin re-
modelling events, as part of DDR. Furthermore, we show
that nuclear envelope relaxation protects against further
damage. It will be of interest, in the future, to determine
the molecular mechanisms through which nuclear mechan-
ics directly influence DNA damage levels as these pathways
may directly influence therapeutic resistance.
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